Enzyme Replacement Therapy (Angiochem/GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEnzyme Replacement Therapy (Angiochem/GlaxoSmithKline)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionEnzymes stimulants

TargetsEnzymes

Therapy Area/IndicationsLysosomal Storage Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAngiochem Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsLysosomal Storage Diseases

ATC CodeN/A